The PEVIVA® Product Line was invented by VLVbio, a Swedish biotechnology company devoted to the manufacture, R&D and sales of unique biomarker assays intended for:

• Non-invasive diagnosis as well as treatment follow-up of certain types of liver diseases.
• Preclinical research in drug development.
• Rapid and non-invasive monitoring of anti-cancer drug efficacy.

VLVbio has, since the establishment of the company, the exclusive rights to the M30® antibody. The M30® is a unique apoptosis marker used in the M30 Apoptosense® ELISA and the M30 CytoDeath™ ELISA, which measures the amount of caspase cleaved keratin 18 leaked from epithelial cells.

VLVbio also offers the M65® ELISA, M65 EpiDeath® and M65 EpiRat™ ELISA. These three assays are based on two anti- keratin 18 mouse monoclonal antibodies (M5 and M6) measuring total cell death (apoptosis and necrosis) by quantifying cleaved and intact keratin 18.